scholarly article | Q13442814 |
P50 | author | Charles V Jackson | Q96204456 |
Karen Zimmerman | Q96204457 | ||
P2093 | author name string | Richard G Peterson | |
Michael K Hansen | |||
Norman Huebert | |||
Willem de Winter | |||
P2860 | cites work | Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure | Q24624286 |
Assessment of pancreatic β-cell function: review of methods and clinical applications | Q26829445 | ||
Recent advances in the molecular genetics of type 2 diabetes mellitus | Q26996335 | ||
Circadian adaptations to meal timing: neuroendocrine mechanisms | Q27000418 | ||
Banting lecture 1988. Role of insulin resistance in human disease | Q29547283 | ||
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants | Q29614188 | ||
Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions | Q30415102 | ||
AVE8134, a novel potent PPARα agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats | Q33567011 | ||
A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus. | Q51501369 | ||
Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance--a population-based twin study. | Q54103713 | ||
Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats | Q73645282 | ||
Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats | Q87405336 | ||
Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes | Q33846858 | ||
Metabolic syndrome X: a review | Q33947888 | ||
Metabolic syndrome: definitions and controversies. | Q35047747 | ||
Pathogenesis of type 2 diabetes mellitus | Q35861736 | ||
Genetics of type 2 diabetes mellitus and obesity--a review | Q36977820 | ||
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
CRP and adiponectin and its oligomers in the metabolic syndrome: evaluation of new laboratory-based biomarkers | Q37148493 | ||
Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models | Q37162300 | ||
Development and characterization of a novel rat model of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat | Q37200126 | ||
Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes | Q37348327 | ||
Loss of coupling between calcium influx, energy consumption and insulin secretion associated with development of hyperglycaemia in the UCD-T2DM rat model of type 2 diabetes | Q37372966 | ||
The use of animal models in the study of diabetes mellitus. | Q37469634 | ||
Age-Related Differences in Response to High-Fat Feeding on Adipose Tissue and Metabolic Profile in ZDSD Rats | Q37515390 | ||
Multiscale analysis of morphology and mechanics in tail tendon from the ZDSD rat model of type 2 diabetes. | Q37571073 | ||
Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats. | Q37621815 | ||
Diabetes and insulin resistance in pediatric obesity | Q37957451 | ||
The prevalence of metabolic syndrome in children: a systematic review of the literature | Q38068227 | ||
Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. | Q39648063 | ||
Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: a new animal model for type 2 diabetes | Q41834115 | ||
A new obesity-prone, glucose-intolerant rat strain (F.DIO). | Q44509590 | ||
Mode of onset of type 2 diabetes from normal or impaired glucose tolerance | Q44704987 | ||
A genetic defect in beta-cell gene expression segregates independently from the fa locus in the ZDF rat. | Q46274158 | ||
Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats | Q46619834 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | metabolic syndrome | Q657193 |
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 487816 | |
P577 | publication date | 2015-04-16 | |
P1433 | published in | Journal of Diabetes Research | Q26841822 |
P1476 | title | Characterization of the ZDSD Rat: A Translational Model for the Study of Metabolic Syndrome and Type 2 Diabetes | |
P478 | volume | 2015 |
Q38822212 | Alternatives to the Streptozotocin-Diabetic Rodent. |
Q42402817 | Changes in the Fracture Resistance of Bone with the Progression of Type 2 Diabetes in the ZDSD Rat. |
Q58737185 | Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus |
Q33825537 | Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse. |
Q39722024 | Modeling the Disease Progression from Healthy to Overt Diabetes in ZDSD Rats |
Q49804048 | The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM). |
Q41965910 | The ZDSD rat: a novel model of diabetic nephropathy |
Q90667295 | Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue |
Q30833537 | Uninephrectomized High-Fat-Fed Nicotinamide-Streptozotocin-Induced Diabetic Rats: A Model for the Investigation of Diabetic Nephropathy in Type 2 Diabetes. |
Q42315902 | Wound Healing Delay in the ZDSD Rat. |
Search more.